Figures & data
Table 1 Baseline demographic and glaucoma status
Figure 1 Means with 95% confidence intervals for IOP at each time point for the KDB-alone and KDB-phaco groups.
![Figure 1 Means with 95% confidence intervals for IOP at each time point for the KDB-alone and KDB-phaco groups.](/cms/asset/8b99ab22-ec99-46e0-bd24-ec7b352ced94/doph_a_12157586_f0001_c.jpg)
Figure 2 Means with 95% confidence intervals for number of medications at each time point for the KDB-alone and KDB-phaco groups.
![Figure 2 Means with 95% confidence intervals for number of medications at each time point for the KDB-alone and KDB-phaco groups.](/cms/asset/d033a5e7-0904-4796-886d-a4c3589cc7df/doph_a_12157586_f0002_c.jpg)
Table 2 Target IOP levels at baseline and at month 24